Main Menu

The Institute of Cancer Research, London, is one of the world’s most influential cancer research organisations. Today, read about six advances in bowel cancer, apply for a PhD studentship or watch our researchers highlight industry interactions.

Back to top
  • Can we cure cancer? Nine challenges scientists say we need to overcome

    Can we cure cancer? Nine challenges scientists say we need to overcome

    Our Head of Content and Partnerships, Henry French, introduces some of the issues that cancer researchers are considering in the search for cancer cures.

    Read more
  • Targeted breast cancer drug – olaparib – given green light by EU

    Targeted breast cancer drug – olaparib – given green light by EU

    European Medicines Agency approves olaparib for women with BRCA-mutant breast cancer – 15 months after licensing in the US.

    Read more
  • Cancers ‘change spots’ to avoid immunotherapy

    Cancers ‘change spots’ to avoid immunotherapy

    Cancers can make themselves harder for new immunotherapies to see by ‘changing their spots’ – and switching off a key molecule on the surface of cells that is otherwise recognised by treatment.

    Read more
  • Sign up for the 2020 London Landmarks Half Marathon

    Sign up for the 2020 London Landmarks Half Marathon

    During April, get your Early Bird discount for the London Landmarks Half Marathon – the quirkiest race in London! Secure a place for only £17.50.

    Sign up
  • How we work with industry

    How we work with industry

    The Enterprise Unit acts as the technology and knowledge transfer hub for The Institute of Cancer Research, providing the experience and expertise to put in place a wide range of agreements between our scientists and industry.

    Read more
1/5

Share your story

We always want to hear from people who have a cancer story to share. Get in touch and help raise awareness of our research.

Find out more

Childhood leukaemia appeal

Our latest research shows that within the next decade, we can make acute lymphoblastic leukaemia preventable. Your support will help us make this disease a thing of the past.

Donate

ICR values

Our values – developed together as an organisation – make it clear how each and every one of us work to meet our mission – to make the discoveries that defeat cancer.

Find out more

Our scientific discoveries

For more than 100 years, the ICR has played an important role in shaping understanding of cancer and how it can be treated.

Find out more

The Drug Discoverer

Our Chief Executive and President, Professor Paul Workman, shares his experiences on his blog, The Drug Discoverer.

Find out more

How we work with industry

We work in close partnership with industry to take results into the clinic as soon as possible, and make sure our research delivers for cancer patients.

Find out more